Avalo Therapeutics AVTX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's lessee operating lease liability undiscounted excess amount?
- Avalo Therapeutics (AVTX) reported lessee operating lease liability undiscounted excess amount of $17K in Q1 2026.
- How has Avalo Therapeutics's lessee operating lease liability undiscounted excess amount changed year-over-year?
- Avalo Therapeutics's lessee operating lease liability undiscounted excess amount decreased by 77.0% year-over-year, from $74K to $17K.